IL-6 174 G/C Polymorphism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

The results of previous studies on the association between IL-6-174G/C (rs1800795) polymorphism and inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC) are not consistent. The present meta-analysis has pooled all eligible studies to understand the relation between this gene polymorphism and IBD risk. A structured search of Medline, EMBASE, and Scopus databases were performed to identify all eligible studies published before June 2017. Odds ratio (OR) and 95% confidence intervals (CIs) were assessed applying fixedor random-effect models to evaluate the strength of association in recessive model, dominant model, allelic model, heterozygote contrast, and homozygotes contrast. A sum of 9 articles with 1524 IBD cases and 1586 healthy subjects were included in this study. No significant association between the IL-6 -174 G/C polymorphism and overall IBD susceptibility in any tested genetic model was found. Moreover, in the subgroup analysis based on subtypes, the associations between the IL-6 174-G/C polymorphism and CD and UC missed statistical significance. The current meta-analysis suggests that the IL6-174 G/C polymorphism is not associated with IBD susceptibility. Further and comprehensive studies are necessary to warrant this result. © 2018 Tehran University of Medical Sciences. All rights reserved. Acta Med Iran 2018;56(12):740-749.

[1]  M. Xu,et al.  Meta-analysis of IL-6 -174G/C polymorphism and psoriasis risk. , 2016, Genetics and molecular research : GMR.

[2]  A. Ananthakrishnan,et al.  Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  A. Paterson,et al.  IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients. , 2016, Journal of Crohn's & colitis.

[4]  S. Nadifi,et al.  Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort , 2015, Genes and Immunity.

[5]  G. Kaplan,et al.  The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.

[6]  C. Hunter,et al.  IL-6 as a keystone cytokine in health and disease , 2015, Nature Immunology.

[7]  A. Minguela,et al.  Pro‐ and anti‐inflammatory cytokine gene single‐nucleotide polymorphisms in inflammatory bowel disease , 2015, International journal of immunogenetics.

[8]  N. Rezaei,et al.  Association of interleukin 6 single nucleotide polymorphisms with allergic rhinitis. , 2014, International journal of pediatric otorhinolaryngology.

[9]  D. Richardson,et al.  Gene of the month: Interleukin 6 (IL-6) , 2014, Journal of Clinical Pathology.

[10]  C. Çekiç,et al.  Evaluation of the relationship between serum ghrelin, C-reactive protein and interleukin-6 levels, and disease activity in inflammatory bowel diseases. , 2014, Hepato-gastroenterology.

[11]  N. Rezaei,et al.  Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus , 2014, European Cytokine Network.

[12]  A. Tewari,et al.  Inflammation and prostate cancer: the role of interleukin 6 (IL‐6) , 2014, BJU international.

[13]  L. Glavaš-Obrovac,et al.  Importance of interleukin 6 in pathogenesis of inflammatory bowel disease. , 2014, Collegium antropologicum.

[14]  G. Tonini,et al.  Impact of Interleukin-6 –174 G>C Gene Promoter Polymorphism on Neuroblastoma , 2013, PloS one.

[15]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[16]  M. Santos,et al.  Interleukin-6 promoter polymorphism −174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients , 2011, Clinical Rheumatology.

[17]  O. Nóbrega,et al.  Effects of 174 G/C polymorphism in the promoter region of the interleukin-6 gene on plasma IL-6 levels and muscle strength in elderly women. , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[18]  F. Shahram,et al.  Proinflammatory cytokine gene polymorphisms in Behçet's disease. , 2010, European cytokine network.

[19]  A. Stanković,et al.  The IL-6 −174G/C polymorphism and renal scarring in children with first acute pyelonephritis , 2010, Pediatric Nephrology.

[20]  A. Kimura,et al.  IL‐6: Regulator of Treg/Th17 balance , 2010, European journal of immunology.

[21]  T. Kishimoto.  IL-6: from its discovery to clinical applications. , 2010, International immunology.

[22]  E. Leshinsky‐Silver,et al.  Early-onset Crohn Disease Is Associated With Male Sex and a Polymorphism in the IL-6 Promoter , 2010, Journal of pediatric gastroenterology and nutrition.

[23]  M. Brito,et al.  Fatty Acids, IL6, and TNFα Polymorphisms: An Example of Nutrigenetics in Crohn's Disease , 2009, The American Journal of Gastroenterology.

[24]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[25]  M. Spehlmann,et al.  IL-6-Dependent Mucosal Protection Prevents Establishment of a Microbial Niche for Attaching/Effacing Lesion-Forming Enteric Bacterial Pathogens1 , 2008, The Journal of Immunology.

[26]  I. Olkin,et al.  The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.

[27]  N. Rezaei,et al.  Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. , 2006, European cytokine network.

[28]  J. Mansfield,et al.  Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn’s disease , 2005, Gut.

[29]  M. Neurath,et al.  Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer , 2005, Clinical reviews in allergy & immunology.

[30]  P. Nickerson,et al.  The Role of Cytokine Gene Polymorphisms in Determining Disease Susceptibility and Phenotype in Inflammatory Bowel Disease , 2005, The American Journal of Gastroenterology.

[31]  G. Abecasis,et al.  A note on exact tests of Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.

[32]  J. Conroy,et al.  Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. , 2004, Mediators of inflammation.

[33]  J. Linseisen,et al.  Association of polymorphisms in Th1, Th2 cytokine genes with hayfever and atopy in a subsample of EPIC‐Heidelberg , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  M. Neurath,et al.  The role of Th1/Th2 polarization in mucosal immunity , 2002, Nature Medicine.

[35]  K. Schulte,et al.  Genetic Determinants of IL-6 Expression Levels Do Not Influence Bone Loss in Inflammatory Bowel Disease , 2001, Digestive Diseases and Sciences.

[36]  C. Folwaczny,et al.  The polymorphism at position −174 of the IL-6 gene is not associated with inflammatory bowel disease , 2001, European journal of gastroenterology & hepatology.

[37]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[38]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[39]  R. Coffman,et al.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.

[40]  B. Woolf.  ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.

[41]  H. Efe,et al.  Analysis of Cytokine Gene Polymorphism Allelic Variation in the TurkishPopulation with Inflammatory Bowel Disease. , 2014 .

[42]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[43]  N. Rezaei,et al.  Association between the interleukin 6 genotype at position -174 and atopic dermatitis. , 2013, Journal of investigational allergology & clinical immunology.